Skip to content

The effect of Commiphora mukul cream improvement of breast engorgement

Investigating the effect of Commiphora mukul cream on improvement of breast engorgement of women referred to the health center of Kerman University of medical science in 2015-2016

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017062633812N2
Enrollment
105
Registered
2017-07-19
Start date
2016-09-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast engorgement. Breast engorgement of newborn

Interventions

Intervention 1: 0.5 ml Placebo cream will be rubbed to breast from the top to the nipple
10 times a day
for 2 days. Intervention 2: 0.5 ml Commiphora mukul cream will be rubbed to breast from the top to the nipple
for 2 days.
Placebo
0.5 ml Placebo cream will be rubbed to breast from the top to the nipple
for 2 days
0.5 ml Commiphora mukul cream will be rubbed to breast from the top to the nipple

Sponsors

Vice Chancellor for research Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: The study inclusion criteria for the Iranian; literate mothers who were in the 1st to 15th days after delivery consisted of having breast engorgement with a minimum intensity score of 2 based on the checklist (with a maximum score of 19); A sublingual temperature below 38 ° C; Having had engorgement symptoms during the first 15 days after delivery; No use of medications for stopping breastfeeding; No use of topical herbal therapies; Not having developed breast abscess or mastitis; No prohibition on lactation; No history of any allergies to Commiphora mukul or other plants; And nursing every 2 to 3 hours. For the neonates, the inclusion criteria consisted of being a singleton and having a full-term birth and normal birth weight (2500-4000 g); Being able to suck on nipples; Not being prohibited from breastfeeding; ?And demanding to be nursed every 2 to 3 hours. The study exclusion criteria for the mothers consisted of the incidence of allergy to Commiphoramukul; A general temperature exceeding 38 ° C after beginning the intervention; Use or need to antiinflammatory medications or painkillers or warm compress or cold compress or acupressure interfering with the designed intervention during the course of the study; And the incidence of unexpected events for either participants interfering with their breastfeeding; Use of the proposed treatment less than five times a day. The infants were excluded from the study if they lost the study inclusion criteria for any reason, including getting a fever during the course of the intervention.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Erythema breast. Timepoint: Before intervention,2 days after intervention. Method of measurement: Check list of breast engorgement.;Breast Tension. Timepoint: Before intervention,2 days after intervention. Method of measurement: Check list of breast engorgement.;Breast pain. Timepoint: Before intervention,2 days after intervention. Method of measurement: Check list of breast engorgement.;Total score breast engorgement. Timepoint: Before intervention,2 days after intervention. Method of measurement: Check list of breast engorgement.

Secondary

MeasureTime frame
Side effects of commiphora mukul cream. Timepoint: Before intervention,2 days after intervention. Method of measurement: Q&A; Visual analog.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahrzad Zolala

Shahid Beheshti University of Sciences,Tehran

shahrzad.zolala@gmail.com+98 21 23871

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026